Phase II study of weekly albumin-bound paclitaxel combined with cisplatin in patients with advanced breast cancer

被引：0
|
作者：
Hu, X. [1 ]
Wang, B. [1 ]
机构：
[1] Fudan Univ, Canc Hosp, Shanghai 200433, Peoples R China
来源：
BREAST | 2011年 / 20卷
关键词：
D O I：
10.1016/S0960-9776(11)70254-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S77 / S77
页数：1
相关论文
共 50 条
  • [21] A randomized phase I trial of nanoparticle albumin-bound paclitaxel with or without mifepristone for advanced breast cancer
    Nanda, Rita
    Stringer-Reasor, Erica M.
    Saha, Poornima
    Kocherginsky, Masha
    Gibson, Jean
    Libao, Bernadette
    Hoffman, Philip C.
    Obeid, Elias
    Merkel, Douglas E.
    Khramtsova, Galina
    Skor, Maxwell
    Krausz, Thomas
    Cohen, Ronald N.
    Ratain, Mark J.
    Fleming, Gini F.
    Conzen, Suzanne D.
    SPRINGERPLUS, 2016, 5
  • [22] Efficacy of two-weekly nanoparticle albumin-bound paclitaxel as neoadjuvant chemotherapy for breast cancer
    Xie, Fei
    Chen, Rui
    Zhang, Ling
    Yin, Zinan
    Zhu, Qiannan
    You, Sainan
    Jiang, Chaojun
    Li, Yan
    Li, Shuo
    Zha, Xiaoming
    Wang, Jue
    NANOMEDICINE, 2019, 14 (12) : 1595 - 1603
  • [23] Phase I/II study of albumin-bound nab-paclitaxel plus gemcitabine administered to Chinese patients with advanced pancreatic cancer
    Zhang, Dong-sheng
    Wang, De-shen
    Wang, Zhi-qiang
    Wang, Feng-hua
    Luo, Hui-yan
    Qiu, Miao-zhen
    Wang, Feng
    Li, Yu-hong
    Xu, Rui-hua
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (04) : 1065 - 1072
  • [24] Phase I/II study of albumin-bound nab-paclitaxel plus gemcitabine administered to Chinese patients with advanced pancreatic cancer
    Dong-sheng Zhang
    De-shen Wang
    Zhi-qiang Wang
    Feng-hua Wang
    Hui-yan Luo
    Miao-zhen Qiu
    Feng Wang
    Yu-hong Li
    Rui-hua Xu
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 1065 - 1072
  • [25] Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane®) in combination with gemcitabine in patients with metastatic breast cancer (N0531)
    Roy, V.
    LaPlant, B. R.
    Gross, G. G.
    Bane, C. L.
    Palmieri, F. M.
    ANNALS OF ONCOLOGY, 2009, 20 (03) : 449 - 453
  • [26] Phase II study of neoadjuvant gemcitabine, epirubicin, and albumin-bound nab paclitaxel (GEA) in locally advanced breast cancer with SPARC tumor assessments
    Yardley, D. A.
    Inhorn, R. C.
    Daniel, D.
    Daniel, B.
    Naot, Y.
    Zubkus, J.
    Simons, L.
    Knauer, D.
    Trieu, V.
    Desai, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [27] Phase I/II study of cisplatin combined with weekly paclitaxel in patients with advanced non-small-cell lung cancer
    Yoshimura, N
    Kudoh, S
    Mukohara, T
    Yamauchi, S
    Yamada, M
    Kawaguchi, T
    Nakaoka, Y
    Hirata, K
    Yoshikawa, J
    BRITISH JOURNAL OF CANCER, 2004, 90 (06) : 1184 - 1189
  • [28] Phase I/II study of cisplatin combined with weekly paclitaxel in patients with advanced non-small-cell lung cancer
    N Yoshimura
    S Kudoh
    T Mukohara
    S Yamauchi
    M Yamada
    T Kawaguchi
    Y Nakaoka
    K Hirata
    J Yoshikawa
    British Journal of Cancer, 2004, 90 : 1184 - 1189
  • [29] Phase II study of paclitaxel combined with vinorelbine in patients with advanced breast cancer
    Spano, JP
    Bouillet, T
    Boaziz, C
    Piperno-Neumann, S
    Brunel, P
    Hennebelle, F
    Amsalhem, P
    Brunet-Pommeyrol, A
    Kanoui, A
    Morin, F
    Breau, JL
    Morere, JF
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2004, 27 (03): : 317 - 321
  • [30] Phase II Study of Weekly Nanoparticle Albumin-Bound Paclitaxel as Second- or Third-Line Therapy in Patients with Advanced Non-Small Cell Lung Cancer
    Kotake, Mie
    Kuwako, Tomohito
    Imai, Hisao
    Tomizawa, Yoshio
    Kaira, Kyoichi
    Yoshii, Akihiro
    Ochiai, Mai
    Miura, Yosuke
    Osaki, Takashi
    Sakurai, Reiko
    Takei, Kousuke
    Minato, Koichi
    Saito, Ryusei
    CHEMOTHERAPY, 2020, 65 (1-2) : 21 - 28
12345